Voronoi Co. Ltd.
310210.KQ
| Exchange: | KQ |
| Currency | Korean Won |
| Open Figi: | BBG014SPCQX7 |
| Fiscal Year End: | December |
| Sector: | Healthcare |
| Industry: | Biotechnology |
| Gic Sector: | Energy |
| Gic Group: | Energy |
| Gic Industry: | Oil, Gas & Consumable Fuels |
| Gic Sub Industry: | Coal & Consumable Fuels |
| Description: | Voronoi, Inc. researches, develops, and discovers small molecule kinase inhibitors in South Korea. Its products pipeline includes VRN01, an oral leucine rich repeat kinase 2 inhibitor targeting glioblastoma multiforme to treat brain and pancreatic cancers; VRN07, VRN06, and VRN11 for the treatment of lung cancer; VRN08 and VRN10 to treat breast cancer; and VRN02 for the treatment of rheumatoid arthritis and atopic dermatitis. The company's products pipeline also comprise VRN04-1 to treat autoimmune diseases; VRN04-2 for the treatment of multiple sclerosis and amyotrophic lateral sclerosis; VRN13 to treat pulmonary arterial hypertension; and VRN14 for the treatment of refractory solid cancer. Voronoi, Inc. was founded in 2015 and is based in Incheon, South Korea. |
| Address: | 32, Songdo Gwawak-ro, Incheon, South Korea, 21984 |
| Website: | https://voronoi.io |
| Full Time Employees: | 126 |
| Updated On: | 2024-11-02 |
Highlights
| Market Capitalization: | 1878314450944 |
| Market Capitalization Mln: | 1878314.45 |
| EBITDA: | -29846734848 |
| Wall Street Target Price: | 85000 |
| Most Recent Quarter: | 2024-06-30 |
| Return On Assets TTM: | -0.29 |
| Return On Equity TTM: | -0.78 |
| Revenue TTM: | 588670336 |
| Revenue Per Share TTM: | 39.91 |
| Quarterly Revenue Growth YOY: | 0.29 |
| Gross Profit TTM: | 9767826850 |
Valuation
| Price Sales TTM: | 24.39 |
| Price Book MRQ: | 27.21 |
| Enterprise Value: | 1829871623780 |
| Enterprise Value Revenue: | 51.14 |
| Enterprise Value Ebitda: | -15.84 |
Shares
| Shares Outstanding: | 17391800 |
| Shares Float: | 10211262 |
| Percent Insiders: | 38.75 |
| Percent Institutions: | 3.14 |
Technicals
| Beta: | 1.92 |
| 52 Week High: | 119200 |
| 52 Week Low: | 28350 |
| 50 Day MA: | 92544 |
| 200 Day MA: | 57570.75 |
Splits & Dividends
| Last Split Factor: | 1.2:1 |
| Last Split Date: | 2023-09-13 |
Earnings
| Report Date: | 2024-06-30 |
| Date: | 2024-06-30 |
| Currency: | KRW |
| Eps Actual: | -445.01 |
| Report Date: | 2024-03-31 |
| Date: | 2024-03-31 |
| Currency: | KRW |
| Eps Actual: | -384.66 |
| Report Date: | 2023-12-31 |
| Date: | 2023-12-31 |
| Currency: | KRW |
| Eps Actual: | -890.36 |
| Report Date: | 2023-09-30 |
| Date: | 2023-09-30 |
| Currency: | KRW |
| Eps Actual: | -395.51 |
| Report Date: | 2023-06-30 |
| Date: | 2023-06-30 |
| Currency: | KRW |
| Eps Actual: | -440.83 |
| Report Date: | 2023-03-31 |
| Date: | 2023-03-31 |
| Currency: | KRW |
| Eps Actual: | -561.31 |
| Report Date: | 2022-12-31 |
| Date: | 2022-12-31 |
| Currency: | KRW |
| Eps Actual: | -621.42 |
| Report Date: | 2022-09-30 |
| Date: | 2022-09-30 |
| Currency: | KRW |
| Eps Actual: | 99.85 |
| Report Date: | 2022-06-30 |
| Date: | 2022-06-30 |
| Currency: | KRW |
| Eps Actual: | -400.79 |
| Date: | 2024-06-30 |
| Eps Actual: | -829.67 |
| Date: | 2023-12-31 |
| Eps Actual: | -2288.03 |
| Date: | 2022-12-31 |
| Eps Actual: | -922.35 |